Asia-Pacific Biochips Market Outlook Report, 2019-2025 – ResearchAndMarkets.comNovember 8, 2019
DUBLIN–(BUSINESS WIRE)–The “Asia-Pacific Biochips Market (2019-2025)” report has been added to ResearchAndMarkets.com’s offering.
The Asia-Pacific Biochips Market is expected to witness market growth of 12.7% CAGR during the forecast period (2019-2025).
The Asia-Pacific region is projected to record the most rapidly evolving healthcare infrastructure, especially in India and China, in the forecast period.
Since biochip technologies themselves are used in sequence technology, their scalability and throughput are the major advantages of biochips. NGS has supported breakthrough scientific developments and technical advances in medicine through the benefits of biochips. However, all existing NGS platforms require the preparation of nucleic acids at certain levels which makes biology-specific systems of interest difficult to analyze.
In the field of biomedical and biotechnological studies, biochips are becoming increasingly used. As the technology in the sector of medicine progresses, the use of proteomics biochips such as microarrays has been increasing. Low sample consumption and their inclination to miniaturization include the benefits of protein biochips. For example, protein microarrays can simultaneously display multiple proteins, which translate into the ability to process thousands of samples in parallel.
Based on Product, the market is segmented into DNA Chip, Protein Chip, Lab-on-Chip and Other Products. Based on Application, the market is segmented into Drug Discovery and Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia-Pacific.
The market research report covers the analysis of key stake holders of the market. Key Companies Profiled in the report include Fluidigm Corporation, Horiba Ltd., PerkinElmer, Inc., OriGene Technologies, Inc., Dynamic Biosensors GmbH, Illumina, Inc., Qiagen N.V., Bio-Rad Laboratories, Inc., Randox Laboratories Limited and Thermo Fisher Scientific, Inc.
Scope of the Study
- DNA Chip
- Protein Chip
- Other Products
- Drug Discovery & Development
- Disease Diagnostics
- Other Applications
- Biotechnology & Pharmaceutical Sector
- Hospitals & Diagnostics Centers
Academic & Research Institutes
- Other End-users
- South Korea
- Rest of Asia-Pacific
- Fluidigm Corporation
- Horiba Ltd.
- PerkinElmer Inc.
- OriGene Technologies Inc.
- Dynamic Biosensors GmbH
- Illumina Inc.
- Qiagen N.V.
- Bio-Rad Laboratories Inc.
- Randox Laboratories Limited
- Thermo Fisher Scientific Inc.
For more information about this report visit https://www.researchandmarkets.com/r/9rsjp0
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900